Access our insights, latest research, leadership trends and more through our Knowledge Center.
Big pharma faces an ever more complicated and high-stakes regulatory environment. Players that can’t develop new capabilities and mind-sets risk being left behind.
The CEO of multinational biopharma company UCB describes how its focus on patients is creating business opportunities and instilling a deeper sense of purpose across the organization.
As governments, payers, and healthcare providers rapidly move toward a health system that focuses on outcomes rather than products and services, pharmaceutical companies are feeling their way toward a new business model: patient-centricity.